253 related articles for article (PubMed ID: 8883118)
1. New biochemical markers of bone resorption derived from collagen breakdown in the study of postmenopausal osteoporosis.
Guerrero R; Diaz Martin MA; Diaz Diego EM; Disla T; Rapado A; de la Piedra C
Osteoporos Int; 1996; 6(4):297-302. PubMed ID: 8883118
[TBL] [Abstract][Full Text] [Related]
2. New biochemical markers of bone resorption in the study of postmenopausal osteoporosis.
de la Piedra C; Traba ML; Dominguez Cabrera C; Sosa Henríquez M
Clin Chim Acta; 1997 Sep; 265(2):225-34. PubMed ID: 9385464
[TBL] [Abstract][Full Text] [Related]
3. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment.
Garnero P; Shih WJ; Gineyts E; Karpf DB; Delmas PD
J Clin Endocrinol Metab; 1994 Dec; 79(6):1693-700. PubMed ID: 7989477
[TBL] [Abstract][Full Text] [Related]
4. Bone resorption in post-menopausal women with normal and low BMD assessed with biochemical markers specific for telopeptide derived degradation products of collagen type I.
Reginster JY; Henrotin Y; Christiansen C; Gamwell-Henriksen E; Bruyere ; Collette J; Christgau S
Calcif Tissue Int; 2001 Sep; 69(3):130-7. PubMed ID: 11683527
[TBL] [Abstract][Full Text] [Related]
5. Bone resorption in healthy and osteoporotic postmenopausal women: comparison markers for serum carboxy-terminal telopeptide of type I collagen and urinary pyridinium cross-links.
Välimäki MJ; Tähtelä R; Jones JD; Peterson JM; Riggs BL
Eur J Endocrinol; 1994 Sep; 131(3):258-62. PubMed ID: 7921210
[TBL] [Abstract][Full Text] [Related]
6. Bone resorption versus estrogen loss following oophorectomy and menopause.
Ohta H; Makita K; Komukai S; Nozawa S
Maturitas; 2002 Sep; 43(1):27-33. PubMed ID: 12270579
[TBL] [Abstract][Full Text] [Related]
7. Change of cross-linked telopeptide of type I collagen (ICTP) and other bone resorption markers in patients with bone fragility fractures.
Takahara K; Kamimura M; Hashidate H; Uchiyama S; Nakagawa H
J Orthop Sci; 2007 May; 12(3):219-26. PubMed ID: 17530373
[TBL] [Abstract][Full Text] [Related]
8. An immunoassay for type I collagen alpha 1 helicoidal peptide 620-633, a new marker of bone resorption in osteoporosis.
Garnero P; Delmas PD
Bone; 2003 Jan; 32(1):20-6. PubMed ID: 12584032
[TBL] [Abstract][Full Text] [Related]
9. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study.
Garnero P; Hausherr E; Chapuy MC; Marcelli C; Grandjean H; Muller C; Cormier C; Bréart G; Meunier PJ; Delmas PD
J Bone Miner Res; 1996 Oct; 11(10):1531-8. PubMed ID: 8889854
[TBL] [Abstract][Full Text] [Related]
10. Biochemical markers of bone turnover after surgical menopause and hormone replacement therapy.
Peris P; Alvarez L; Monegal A; Guañabens N; Durán M; Pons F; Martínez de Osaba MJ; Echevarría M; Ballesta AM; Muñoz-Gómez J
Bone; 1999 Sep; 25(3):349-53. PubMed ID: 10495139
[TBL] [Abstract][Full Text] [Related]
11. Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis.
Guañabens N; Parés A; Alvarez L; Martínez de Osaba MJ; Monegal A; Peris P; Ballesta AM; Rodés J
J Bone Miner Res; 1998 Apr; 13(4):731-8. PubMed ID: 9580479
[TBL] [Abstract][Full Text] [Related]
12. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?
Langdahl BL; Loft AG; Møller N; Weeke J; Eriksen EF; Mosekilde L; Charles P
J Bone Miner Res; 1997 Jan; 12(1):78-88. PubMed ID: 9240729
[TBL] [Abstract][Full Text] [Related]
13. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
[TBL] [Abstract][Full Text] [Related]
14. Significance of serum CrossLaps as a predictor of changes in bone mineral density during estrogen replacement therapy; comparison with serum carboxyterminal telopeptide of type I collagen and urinary deoxypyridinoline.
Okabe R; Inaba M; Nakatsuka K; Miki T; Naka H; Moriguchi A; Nishizawa Y
J Bone Miner Metab; 2004; 22(2):127-31. PubMed ID: 14999523
[TBL] [Abstract][Full Text] [Related]
15. Comparison of serum and urinary C-terminal telopeptide of type I collagen in aging, menopause and osteoporosis.
Kawana K; Takahashi M; Hoshino H; Kushida K
Clin Chim Acta; 2002 Feb; 316(1-2):109-15. PubMed ID: 11750280
[TBL] [Abstract][Full Text] [Related]
16. Biochemical markers of bone turnover and response of bone mineral density to intervention in early postmenopausal women: an experience in a clinical laboratory.
Chailurkit LO; Ongphiphadhanakul B; Piaseu N; Saetung S; Rajatanavin R
Clin Chem; 2001 Jun; 47(6):1083-8. PubMed ID: 11375295
[TBL] [Abstract][Full Text] [Related]
17. Bone turnover and its relationship with bone mineral density in pre- and postmenopausal women with or without fractures.
Minisola S; Pacitti MT; Ombricolo E; Costa G; Scarda A; Palombo E; Rosso R
Maturitas; 1998 Jun; 29(3):265-70. PubMed ID: 9699199
[TBL] [Abstract][Full Text] [Related]
18. Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study.
Garnero P; Sornay-Rendu E; Claustrat B; Delmas PD
J Bone Miner Res; 2000 Aug; 15(8):1526-36. PubMed ID: 10934651
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a fully automated serum assay for C-terminal cross-linking telopeptide of type I collagen in osteoporosis.
Garnero P; Borel O; Delmas PD
Clin Chem; 2001 Apr; 47(4):694-702. PubMed ID: 11274020
[TBL] [Abstract][Full Text] [Related]
20. Effect of risedronate on biochemical marker of bone resorption in postmenopausal women with osteoporosis or osteopenia.
Dane C; Dane B; Cetin A; Erginbas M
Gynecol Endocrinol; 2008 Apr; 24(4):207-13. PubMed ID: 18382907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
